What We Do
Diagnamics specializes in the conduct of clinical trials, which are rigorous research studies designed to evaluate new medical treatments, devices, or approaches to care. Each study follows strict scientific and ethical standards to measure safety, effectiveness, and potential benefits for patients. Clinical trials are an essential step in developing new therapies, from early testing to confirming results in larger populations.
The organization responsible for designing and funding a clinical trial is called a sponsor. There are many different types of sponsors, including pharmaceutical companies, academic medical centers, advocacy groups, and federal agencies, such as the National Institute of Health, Department of Health and Human Services, and the Center for Disease Control and Prevention.
Regardless of who sponsors a study, every clinical trial must be monitored by an independent ethics committee, also known as an Institutional Review Board (IRB). These are independent bodies of medical, scientific, and non-scientific members whose responsibility is to review and approve research protocols and monitor ongoing trials in order to ensure that the rights, safety, and well-being of participants are protected.
The Phases of a Clinical Trial
Clinical trials progress through several phases, each with a unique purpose:
Phase 1
Tests a new intervention in a small group to evaluate safety and determine whether it may be effective in treating a specific condition.
Phase 2
Expands to include more participants to assess effectiveness at different dosages and further monitor safety, side effects, and risk factors.
Phase 3
Involves large groups to confirm results, compare to standard treatments, and collect more safety data in order to submit the drug or treatment to the FDA for approval.
Phase 4
Conducted after the intervention receives FDA approval, these studies gather long-term information on effectiveness and side effects in broader patient populations.
How It Works
What to Expect When You Join a Clinical Trial at Diagnamics
1. Contact Us
After you submit your contact information, a member of our research team will reach out to you via call or text using a secure, encrypted line and ask you to complete a quick, confidential questionnaire to determine your eligibility and level of interest.
2. Pre-Screening Call
If you pre-qualify based on your questionnaire responses, our research team will schedule a phone call to review your medical history and discuss the details of the research study, including the potential risks and benefits. The information you share over the phone is confidential and will only be used to determine your eligibility. If the study seems like it may be a good fit for you, we will work with you to schedule your in-person screening visit.
3. Screening Clinic Visit
When you arrive at the clinic on the day of your screening visit, you will meet with the study doctor and research coordinator for an in-depth review of your medical history, the study protocol, expectations, and procedures. After signing an informed consent form, you will be asked to complete study-related medical exams and other tasks to ensure that you are the right fit to volunteer for the trial.
4. Eligibility Verification
The study doctor will review and ascertain your candidacy based on the results from your screening visit. The research coordinator will then call and inform you of the decision. If you are eligible, your next visit will be scheduled in accordance with the study protocol. If it is determined that you don’t qualify, we encourage you to apply for future studies. You never know which clinical trial will be the right fit!